A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
出版年份 2013 全文链接
标题
A phase I study investigating the safety and pharmacokinetics of highly bioavailable curcumin (Theracurmin®) in cancer patients
作者
关键词
Curcumin, Bioavailability, Theracurmin<sup>®</sup>, Gemcitabine, Pancreatic cancer
出版物
CANCER CHEMOTHERAPY AND PHARMACOLOGY
Volume 71, Issue 6, Pages 1521-1530
出版商
Springer Nature
发表日期
2013-03-29
DOI
10.1007/s00280-013-2151-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Dose escalation and pharmacokinetic study of nanoparticle curcumin… by Kanai et al., CCP 69:65–70, 2012
- (2012) Andreas J. Gescher CANCER CHEMOTHERAPY AND PHARMACOLOGY
- In response
- (2012) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Innovative Preparation of Curcumin for Improved Oral Bioavailability
- (2011) Hiroki Sasaki et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Dose-escalation and pharmacokinetic study of nanoparticle curcumin, a potential anticancer agent with improved bioavailability, in healthy human volunteers
- (2011) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Advanced Drug Delivery Systems of Curcumin for Cancer Chemoprevention
- (2011) S. S. Bansal et al. Cancer Prevention Research
- Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis
- (2011) Atsuko Sato et al. CANCER SCIENCE
- Best supportive care (BSC) versus oxaliplatin, folinic acid and 5-fluorouracil (OFF) plus BSC in patients for second-line advanced pancreatic cancer: A phase III-study from the German CONKO-study group
- (2011) Uwe Pelzer et al. EUROPEAN JOURNAL OF CANCER
- A multi-institution phase II study of gemcitabine/S-1 combination chemotherapy for patients with advanced biliary tract cancer
- (2010) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase I/II study of gemcitabine-based chemotherapy plus curcumin for patients with gemcitabine-resistant pancreatic cancer
- (2010) Masashi Kanai et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Gemcitabine Sensitivity Can Be Induced in Pancreatic Cancer Cells through Modulation of miR-200 and miR-21 Expression by Curcumin or Its Analogue CDF
- (2010) Shadan Ali et al. CANCER RESEARCH
- Novel Heart Failure Therapy Targeting Transcriptional Pathway in Cardiomyocytes by a Natural Compound, Curcumin
- (2010) Tatsuya Morimoto et al. CIRCULATION JOURNAL
- Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
- (2010) Jennifer S. Temel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Curcumin and Gemcitabine in Patients With Advanced Pancreatic Cancer
- (2010) Ron Epelbaum et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Nanoparticle encapsulation improves oral bioavailability of curcumin by at least 9-fold when compared to curcumin administered with piperine as absorption enhancer
- (2009) J. Shaikh et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Encapsulation of curcumin in alginate-chitosan-pluronic composite nanoparticles for delivery to cancer cells
- (2009) Ratul Kumar Das et al. Nanomedicine-Nanotechnology Biology and Medicine
- Pharmacokinetics of Curcumin Conjugate Metabolites in Healthy Human Subjects
- (2008) S. K. Vareed et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer
- (2008) N. Dhillon et al. CLINICAL CANCER RESEARCH
- Curcumin, a polyphenolic antioxidant, attenuates chronic fatigue syndrome in murine water immersion stress model
- (2008) Amit Gupta et al. IMMUNOBIOLOGY
- Curcumin: Preventive and Therapeutic Properties in Laboratory Studies and Clinical Trials
- (2007) Alexios S. Strimpakos et al. ANTIOXIDANTS & REDOX SIGNALING
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started